William D Bennett1,2, Miao Xie3, Kirby Zeman1, Harry Hurd3, Scott Donaldson2. 1. 1Center for Environmental Medicine, Asthma, and Lung Biology, University of North Carolina, Chapel Hill, North Carolina. 2. 2Pulmonary Medicine, University of North Carolina, Chapel Hill, North Carolina. 3. 3Department of Statistics and Operations Research, University of North Carolina, Chapel Hill, North Carolina.
Abstract
BACKGROUND: Heterogeneity of inhaled particle deposition in airways disease may be a sensitive indicator of physiologic changes in the lungs. Using planar gamma scintigraphy, we developed new methods to locate and quantify regions of high (hot) and low (cold) particle deposition in the lungs. METHODS: Initial deposition and 24 hour retention images were obtained from healthy (n=31) adult subjects and patients with mild cystic fibrosis lung disease (CF) (n=14) following inhalation of radiolabeled particles (Tc99m-sulfur colloid, 5.4 μm MMAD) under controlled breathing conditions. The initial deposition image of the right lung was normalized to (i.e., same median pixel value), and then divided by, a transmission (Tc99m) image in the same individual to obtain a pixel-by-pixel ratio image. Hot spots were defined where pixel values in the deposition image were greater than 2X those of the transmission, and cold spots as pixels where the deposition image was less than 0.5X of the transmission. The number ratio (NR) of the hot and cold pixels to total lung pixels, and the sum ratio (SR) of total counts in hot pixels to total lung counts were compared between healthy and CF subjects. Other traditional measures of regional particle deposition, nC/P and skew of the pixel count histogram distribution, were also compared. RESULTS: The NR of cold spots was greater in mild CF, 0.221±0.047(CF) vs. 0.186±0.038 (healthy) (p<0.005) and was significantly correlated with FEV1 %pred in the patients (R=-0.70). nC/P (central to peripheral count ratio), skew of the count histogram, and hot NR or SR were not different between the healthy and mild CF patients. CONCLUSIONS: These methods may provide more sensitive measures of airway function and localization of deposition that might be useful for assessing treatment efficacy in these patients.
BACKGROUND: Heterogeneity of inhaled particle deposition in airways disease may be a sensitive indicator of physiologic changes in the lungs. Using planar gamma scintigraphy, we developed new methods to locate and quantify regions of high (hot) and low (cold) particle deposition in the lungs. METHODS: Initial deposition and 24 hour retention images were obtained from healthy (n=31) adult subjects and patients with mild cystic fibrosis lung disease (CF) (n=14) following inhalation of radiolabeled particles (Tc99m-sulfur colloid, 5.4 μm MMAD) under controlled breathing conditions. The initial deposition image of the right lung was normalized to (i.e., same median pixel value), and then divided by, a transmission (Tc99m) image in the same individual to obtain a pixel-by-pixel ratio image. Hot spots were defined where pixel values in the deposition image were greater than 2X those of the transmission, and cold spots as pixels where the deposition image was less than 0.5X of the transmission. The number ratio (NR) of the hot and cold pixels to total lung pixels, and the sum ratio (SR) of total counts in hot pixels to total lung counts were compared between healthy and CF subjects. Other traditional measures of regional particle deposition, nC/P and skew of the pixel count histogram distribution, were also compared. RESULTS: The NR of cold spots was greater in mild CF, 0.221±0.047(CF) vs. 0.186±0.038 (healthy) (p<0.005) and was significantly correlated with FEV1 %pred in the patients (R=-0.70). nC/P (central to peripheral count ratio), skew of the count histogram, and hot NR or SR were not different between the healthy and mild CF patients. CONCLUSIONS: These methods may provide more sensitive measures of airway function and localization of deposition that might be useful for assessing treatment efficacy in these patients.
Authors: Scott H Donaldson; Beth L Laube; Timothy E Corcoran; Pradeep Bhambhvani; Kirby Zeman; Agathe Ceppe; Pamela L Zeitlin; Peter J Mogayzel; Michael Boyle; Landon W Locke; Michael M Myerburg; Joseph M Pilewski; Brian Flanagan; Steven M Rowe; William D Bennett Journal: JCI Insight Date: 2018-12-20
Authors: Luciana Alcoforado; Armèle Dornelas de Andrade; Joaquin L Herraiz; Simone Cristina Soares Brandão; Jacqueline de Melo Barcelar; James B Fink; Jose G Venegas Journal: J Aerosol Med Pulm Drug Deliv Date: 2018-04-19 Impact factor: 2.849
Authors: William D Bennett; Kirby L Zeman; Beth L Laube; Jihong Wu; Gail Sharpless; Peter J Mogayzel; Scott H Donaldson Journal: J Aerosol Med Pulm Drug Deliv Date: 2017-10-16 Impact factor: 2.849
Authors: Jay M Newby; Ian Seim; Martin Lysy; Yun Ling; Justin Huckaby; Samuel K Lai; M Gregory Forest Journal: Adv Drug Deliv Rev Date: 2017-12-12 Impact factor: 15.470
Authors: David A Kaminsky; Nirav Daphtary; Raul S J Estepar; Taka Ashikaga; Lukas Mikulic; Jeffrey Klein; C Matthew Kinsey Journal: Acad Radiol Date: 2019-08-27 Impact factor: 5.482
Authors: Yael-Natalie H Escobar; Cameron B Morrison; Yuzhi Chen; Elise Hickman; Charlotte A Love; Meghan E Rebuli; Jason D Surratt; Camille Ehre; Ilona Jaspers Journal: Am J Physiol Lung Cell Mol Physiol Date: 2021-04-07 Impact factor: 6.011